Loyola Medicine is the first center in the Midwest to offer the first effective PET/CT scan for prostate cancer patients. The scan can detect the location and extent of cancer that has recurred after initial treatment. Prostate PET/CT scans can detect cancer earlier than either CT scans alone or MRI scans.
The dreaded finger exam to check for prostate cancer used to be a mainstay of check-ups for older men. With its value now in question, some doctors share the risks and benefits with their patients and let them decide. So, should they or shouldn’t they? Research suggests that in most cases, it is time to abandon the test, says Wake Forest Baptist urologist Ryan Terlecki, M.D., “The evidence suggests that in most cases, it is time to abandon the digital rectal exam (DRE),” said Ryan Terlecki, M.D., a
Mount Sinai Experts are Making Strides in Prostate Cancer Treatment
The top causes of death among adult men in the United Sates are heart disease, stroke, cancer and chronic lower respiratory disease, according to the Mayo Clinic and the Centers for Disease Control (CDC). In a recent issue of Food Technology magazine published by the Institute of Food Technologists, contributing editor Linda Milo Ohr writes about some of the health concerns men have and the nutrients that may play beneficial roles in addressing them.
A novel MRI method that detects low levels of zinc ion can help distinguish healthy prostate tissue from cancer, UT Southwestern Medical Center radiologists have determined.
Research from investigators at Rutgers Cancer Institute of New Jersey; University of California, Los Angeles; University of California, Santa Cruz and other institutions shows a computational approach examining abnormal “signaling” in clinical prostate cancer tissues that is responsible for their spread and resistance to treatment and can help identify patient subsets for targeted therapies.
For the first time in Los Angeles County history, more Latinos than whites are being diagnosed with testicular cancer, a malady once regarded as a white man’s disease. This Q&A focuses on testicular cancer: who is at risk, why they are at risk and what preventive measures can be taken.
Prostate cancer researchers studying genetic variations have pinpointed 45 genes associated with disease development and progression.
Study maps out abnormal signaling pathways in prostate cancer cells and provides computational approaches to identify individualized targets for therapy
Sanford Burnham Prebys Medical Discovery Institute (SBP) has received a $1M donation from The Epstein Family Foundation for scientists to study pancreatic and prostate cancer. The gift, contributed by SBP board member Dan Epstein and his wife Phyllis, will support the lab of Nicholas Cosford, Ph.D., associate director of Translational Research at the Institute’s NCI-designated Cancer Center.
A study at Columbia University's Mailman School of Public Health showed that obesity was more prevalent in patients with a history of cancer than in the general population, and survivors of colorectal and breast cancers were particularly affected. The study is among the first to compare rates of obesity among U.S. cancer survivors and adults without a history of cancer. Findings are published online in the Journal of Clinical Oncology.
Men with very high-risk prostate cancer, who are treated at hospitals with a high proportion of administered radical local treatment (radiotherapy or prostatectomy), only have half of the mortality risk of men who are treated at hospitals with the lowest proportion. This is according to a new study conducted by researchers at Umeå University in Sweden and published in European Urology.
In the search for new ways to attack recurrent prostate cancer, researchers at Duke Health report that a novel compound appears to have a unique way of blocking testosterone from fueling the tumors in mice.
Whether an HIV-positive man has met cultural expectations of masculinity might impact how much stigma he experiences, according to a new study from Binghamton University, State University of New York.
Men with testicular cancer who were uninsured or on Medicaid had a higher risk of death from what is normally a curable disease than insured patients, a new study by Dana-Farber Cancer Institute researchers found.
In a retrospective study analyzing patients' medical records, researchers at Brigham and Women's Hospital found that patients' race significantly affected their longevity by increasing the likelihood of death after receiving androgen deprivation therapy (ADT). ADT was used to reduce the size of the prostate to make a patient eligible for prostate brachytherapy. These findings are published in the August 4, 2016 issue of Cancer.
Using cardiac CT scans, researchers found an association between higher inflammatory biomarkers and a significantly higher prevalence of coronary artery disease in men infected with HIV
Explore significant research developments and treatment advances relevant to oncology pharmacists presented at the ASCO Annual Meeting at the Updates from the American Society of Clinical Oncology (ASCO) Annual Meeting webinar on September 29, 2016, from 12:00 – 1:00 pm CST. This is the final live presentation in the 2016 Emerging Issues in Oncology Webinar Series for Board Certified Oncology Pharmacy recertification opportunities presented by the Hematology/Oncology Pharmacy Association (HOPA).
Patients suffering from deadly heart attacks can be spared more extensive heart damage when emergency responders and hospitals work together to standardize their treatment processes, according to a study published August 1 in Circulation, a journal of the American Heart Association (AHA).
Study by UCLA scientists provides convincing evidence that radiation-based treatments and surgery are equally effective for aggressive prostate cancer.
Although it reads like European license plate number, a protein known as ZMYND8 has demonstrated its ability to block metastasis-linked genes in prostate cancer, according to a study at The University of Texas MD Anderson Cancer Center.
Urologist Dr. Jesse Mills believes not enough attention is paid to male infertility. He wants to shine a light on the causes of infertility and the things that can be done to combat the condition.
VCU Health radiologist Jinxing Yu, M.D., uses magnetic resonance technology to diagnose with more than 90 percent success rate.
Click here to go directly to the Cardiovascular Health News Source
The Center for Behavioral Neuroscience (CBN) at Georgia State University has received a five-year, $3.2 million grant from the National Institute of Mental Health to investigate the neurochemical mechanisms underlying social stress in males and females.
The number of new cases of metastatic prostate cancer climbed 72 percent in the past decade from 2004 to 2013, reports a new Northwestern Medicine study. The authors suspect the recent trend of fewer men being screened and more aggressive disease may be contributing to the rise. The largest increase in new cases was among men 55 to 69 years old, which rose 92 percent in the past decade. This rise is troubling because men in this age group are believed to benefit most from prostate cancer screening and early treatment.
Increasing the number of men who undergo circumcision and increasing the rates at which women with HIV are given antiretroviral therapy (ART) were associated with significant declines in the number of new male HIV infections in rural Ugandan communities, new Johns Hopkins Bloomberg School of Health research suggests.
With commercial sperm banking giving women more opportunities to become mothers, a world-first QUT study has found the age and education of sperm donors are the most important characteristics considered.
Men with metastatic prostate cancer should be considered for germline genetic testing of DNA repair genes, regardless of age or family history, according to a team of researchers from Memorial Sloan Kettering Cancer Center (MSK), Fred Hutchinson Cancer Research Center, Dana-Farber Cancer Institute, University of Washington School of Medicine, University of Michigan, and the Institute of Cancer Research Royal Marsden Hospital.
This groundbreaking study revealed that more than 10 percent of men with aggressive prostate cancer that has spread outside of the prostate have inherited mutations in DNA repair genes — more than four times the rate of the general population and more than twice the rate of men with localized prostate cancer. Men with such mutations could benefit from targeted treatment already approved for ovarian cancer patients with these mutations, such as PARP inhibitors or platinum drugs.
When women feel a lump in their breast, they usually seek medical attention within a few weeks. Yet men who notice something abnormal in a testicle typically don't see a doctor for two to three months.
Older men with low libido and low testosterone levels showed more interest in sex and engaged in more sexual activity when they underwent testosterone therapy, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Men who sleep either fewer or more hours than average may face a greater risk of developing diabetes, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Researchers at the Ontario Institute for Cancer Research (OICR) and University Health Network (UHN) in Toronto, along with researchers at the Eastern Virginia Medical School, have created protein signatures that accurately diagnose prostate cancer and can distinguish between patients with aggressive versus non-aggressive disease using a simple urine sample.
Prostate cancer researchers have discovered biomarkers using non-invasive liquid biopsies to identify aggressive disease before surgery.
NYU Lutheran is determined to help stop prostate cancer in its tracks. And leading NYU Lutheran’s fight is Marc Bjurlin, DO, the hospital’s newly appointed director of urologic oncology and clinical assistant professor of urology at NYU School of Medicine.
In an effort to address widespread concerns related to testosterone deficiency (TD) and its treatment with testosterone therapy, a group of international experts has developed a set of resolutions and conclusions to provide clarity for physicians and patients. At a consensus conference held in Prague, Czech Republic last fall, the experts debated nine resolutions, with unanimous approval. The details of the conference were published today in a Mayo Clinic Proceedings report.
Women live longer than men. This simple statement holds a tantalizing riddle that Steven Austad, Ph.D., and Kathleen Fischer, Ph.D., of the University of Alabama at Birmingham explore in a perspective piece published in Cell Metabolism on June 14.
Prostate cancer patients may soon have a new option to treat their disease: laser heat. UCLA researchers have found that focal laser ablation – the precise application of heat via laser to a tumor – is both feasible and safe in men with intermediate risk prostate cancer.
Publication in Genes & Development: researchers at the Université libre de Bruxelles, ULB develop new techniques to assess the fate of stem cells in vivo.
Click here to go directly to the Food Science News Source
The prevalence of obesity in 2013- 2014 was 35 percent among men and 40 percent among women, and between 2005 and 2014, there was an increase in prevalence among women, but not men, according to a study appearing in the June 7 issue of JAMA.
Get the latest research and features in healthcare, including hospital administration, patient care, and health economics in Newswise's Healthcare News Source.
Physicians have long used magnetic resonance imaging (MRI) to detect cancer but results of a University of California San Diego School of Medicine study describe the potential use of restriction spectrum imaging (RSI) as an imaging biomarker that enhances the ability of MRI to differentiate aggressive prostate cancer from low-grade or benign tumors and guide treatment and biopsy.
Among black men, those with a high degree of West African genetic ancestry have less abdominal fat than those with a lower degree.
Prior research has shown a link between the impact of contracting economies, especially as reflected by the unemployment rate, and suicide mortality risk. This study assesses changes in the rate of heavy alcohol use among suicide decedents, for both genders, during the 2008-2009 economic crisis.
Click to visit the Aging Channel
Weizmann Institute of Science researchers found that a stress receptor in the brain regulates metabolic responses to stressful situations differently in male and female mice. The results could aid in the development of treatments for regulating hunger or stress responses, including anxiety and depression.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right